11
Feb

Advaxis has signed a deal to study its in-development immuno-oncology candidate in tandem with a complementary cancer drug from Incyte, the latest combo trial in a field rife with collaboration.

…read more

Source: Advaxis and Incyte pair off amid immuno-oncology’s partnering blitz

    

0 No comments